First Probable Monkeypox Case Has Been Identified in Detroit

https://www.clickondetroit.com/news/local/2022/07/07/first-probable-monkeypox-case-has-been-identified-in-detroit-officials-say/

byCharles Gross

July 7, 2022

1 minute read

https://www.clickondetroit.com/news/local/2022/07/07/first-probable-monkeypox-case-has-been-identified-in-detroit-officials-say/

Barclays Downgrades Pegasystems to Underweight, Lowers Price Target to $25

By Benzinga Newsdesk

October 18, 6:17 AM

Barclays analyst Raimo Lenschow downgrades Pegasystems (NASDAQ:PEGA) from Equal-Weight to Underweight and lowers the price target from $50 to $25.

PEGA

Mangoceuticals Develops Oral GLP-1s: Stock Soars

By Erica Kollmann

May 21, 10:56 AM

Mangoceuticals announced the development of proprietary oral formulations of Semaglutide ("Slim") and Tirzepatide ("Trim") to aid in weight management and said it plans to have the products available for customers in the beginning of the 3rd quarter with ‘Slim' and ‘Trim' priced at $299/month and $399/month, respectively.

MGRX

Celldex Announces Upcoming Presentation Of Barzolvolimab Phase 2 Results In Chronic Spontaneous Urticaria At AAAAI 2024

By Benzinga Newsdesk

February 5, 9:12 AM

Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that an abstract describing 12 week results from the Company's Phase 2 clinical trial of barzolvolimab in patients with moderate to severe chronic spontaneous

CLDX